Comparative health risk assessment of realgar and NiuHuangJieDu tablets based on tissue arsenic levels after multiple oral administration to rats
- 1 November 2019
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 249, 112370
- https://doi.org/10.1016/j.jep.2019.112370
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81173648)
- Research Innovation Program for College Graduates of Jiangsu Province (1150011652)
This publication has 24 references indexed in Scilit:
- Toxic epidermal necrolysis after extensive dermal use of realgar-containing (arsenic sulfide) herbal ointmentClinical Toxicology, 2013
- Lead, Mercury, and Arsenic Poisoning Due to Topical Use of Traditional Chinese MedicinesThe American Journal of Medicine, 2013
- Bioaccessibility of lead and arsenic in traditional Indian medicinesScience of The Total Environment, 2011
- Assessment of the solubility and bioaccessibility of arsenic in realgar wine using a simulated gastrointestinal systemScience of The Total Environment, 2011
- Reduced arsenic clearance and increased toxicity in aquaglyceroporin-9-null miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Liver is a Target of Arsenic CarcinogenesisToxicological Sciences, 2008
- Mineral Arsenicals in Traditional Medicines: Orpiment, Realgar, and ArsenoliteThe Journal of pharmacology and experimental therapeutics, 2008
- Herbal preparation of realgar induces acute renal failureClinical Toxicology, 2008
- From traditional Chinese medicine to rational cancer therapyTrends in Molecular Medicine, 2007
- Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pillsToxicology and Applied Pharmacology, 2007